BioCentury
ARTICLE | Company News

Bausch wins $195M bid to acquire bankrupt Synergy's assets

March 1, 2019 7:33 PM UTC

Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC) won a $195 million bid to acquire assets of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) in a court-supervised bankruptcy auction. Synergy markets gastrointestinal drug Trulance plecanatide. Trulance is an uroguanylin analog and guanylate cyclase C (GCC; GUCY2C) agonist.

In November, Synergy said it expects 2018 Trulance sales of $42-$47 million...